1. Home
  2. LIF vs IMNM Comparison

LIF vs IMNM Comparison

Compare LIF & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Life360 Inc.

LIF

Life360 Inc.

HOLD

Current Price

$39.75

Market Cap

3.1B

Sector

N/A

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$23.05

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIF
IMNM
Founded
2008
2006
Country
United States
United States
Employees
547
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LIF
IMNM
Price
$39.75
$23.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
10
Target Price
$77.31
$32.80
AVG Volume (30 Days)
1.2M
1.2M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.40
EPS
N/A
N/A
Revenue
N/A
$6,941,000.00
Revenue This Year
$36.28
N/A
Revenue Next Year
$20.85
$1,127.34
P/E Ratio
$425.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.58
$6.97
52 Week High
$112.54
$27.65

Technical Indicators

Market Signals
Indicator
LIF
IMNM
Relative Strength Index (RSI) 42.82 60.73
Support Level $37.61 $19.23
Resistance Level $42.15 $27.14
Average True Range (ATR) 2.28 1.16
MACD 0.38 0.28
Stochastic Oscillator 26.64 90.71

Price Performance

Historical Comparison
LIF
IMNM

About LIF Life360 Inc.

Life360 is the world's largest family focused social network, with nearly 100 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: